To improve access to prescription drugs.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Representative for Pennsylvania's 3rd congressional district. Republican.
Last Updated: May 19, 2017
Length: 13 pages
May 19, 2017
115th Congress, 2017–2019
Died in a previous Congress
This bill was introduced on May 19, 2017, in a previous session of Congress, but was not enacted.
May 19, 2017
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
H.R. 2562 (115th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 115th Congress, which met from Jan 3, 2017 to Jan 3, 2019. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2019). H.R. 2562 — 115th Congress: Making Pharmaceutical Markets More Competitive Act. Retrieved from https://www.govtrack.us/congress/bills/115/hr2562
“H.R. 2562 — 115th Congress: Making Pharmaceutical Markets More Competitive Act.” www.GovTrack.us. 2017. May 23, 2019 <https://www.govtrack.us/congress/bills/115/hr2562>
Making Pharmaceutical Markets More Competitive Act, H.R. 2562, 115th Cong. (2017).
|title=H.R. 2562 (115th)
|accessdate=May 23, 2019
|author=115th Congress (2017)
|date=May 19, 2017
|quote=Making Pharmaceutical Markets More Competitive Act
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.